Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancerOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined how the gut microbial community changes over time during the development of colitis-associated colorectal cancer. Researchers used azoxymethane/dextran sodium sulphate (AOM/DSS) treated mice as a model of chronic colitis progressing to cancer, comparing them against control mice. They applied high-throughput sequencing of the bacterial 16S rRNA gene (V3 region) to track longitudinal shifts in microbial community structure. They also measured a molecular network of six interconnected factors linking inflammation to cancer to see how microbiome changes corresponded with disease pathogenesis.
Who was studied?
The study population was AOM/DSS treated mice modeling colitis-associated colorectal cancer, compared against untreated control mice. Sampling occurred longitudinally, with phylotype and molecular measurements taken after each AOM/DSS treatment cycle. This is an animal model study rather than a human cohort, so no patient demographic details apply.
What were the most important findings?
Chronic colitis significantly altered the structure of the gut microbial community over time. Specific microbes, including Streptococcus luteciae, Lactobacillus hamster, Bacteroides uniformis, and Bacteroides ovatus, increased in abundance during colorectal carcinogenesis. These microbial shifts correlated with changes in a six-factor molecular network (p65, p53, COX-2, PPARgamma, CCR2, and beta-catenin) spanning inflammation to cancer pathways. The longitudinal microbial network constructed from these data showed that phylotype shifts across AOM/DSS cycles were complex and highly dynamic rather than following a simple linear pattern.
What are the greatest implications of this study?
The findings suggest that specific bacterial taxa track closely with the molecular pathogenesis of colitis-associated colorectal cancer, supporting a mechanistic link between microbiome shifts and disease progression. Mapping dynamic microbe and molecule networks over time, rather than single time-point snapshots, may better capture how gut bacteria contribute to carcinogenesis. This network-based approach could help identify candidate microbial markers or targets tied to specific stages of inflammation-driven cancer development. Because this is a mouse model, further work would be needed to confirm relevance to human colitis-associated colorectal cancer.